Featured Research

from universities, journals, and other organizations

Brain saver: Vitamin E supplement helps 'redirect' blood during stroke

Date:
April 29, 2014
Source:
Ohio State University Center for Clinical and Translational Science
Summary:
Strokes are a leading cause of death and long term disability in the US. With the failure of more than 1,000 experimental neuroprotective drugs, one scientist has stopped trying to discover the next new stroke treatment, and instead is trying to prevent strokes from happening in the first place. He thinks he may have found the answer in a little known member of the vitamin E family, which appears to remodel the brain’s circulatory system and provide protection the instant a stroke strikes.

During a stroke, areas of the brain are damaged when deprived of oxygen- rich blood. Here, dark gray patches show scientists what parts of the brain are being "choked" by a stroke.
Credit: Cameron Rink, PhD, The Ohio State University Wexner Medical Center

Dr. Cameron Rink is pointing at a picture of a brain in the middle of a stroke. Dark feathery arteries branch across grayish brain tissue, some of which has faded into black around the obstructed blood vessels, looking like a city block that's lost power while the rest glows on.

Related Articles


"That part of the brain is not getting blood or oxygen and the cells are dying. There's not much we can do for a patient at this point and that's frustrating," says Rink, a professor of surgery at The Ohio State University Wexner Medical Center.

His frustration is well founded. After 25 years and the failure of more than 1,000 experimental neuroprotective drugs, only aspirin and tPA, the 'clot-busting' drug are currently available to patients after they've had stroke -- and tPA can only be used in about 4% of all stroke cases.

Convinced that the "after the fact" approach to stroke doesn't do enough to prevent disability and death, for the past 12 years, Rink has focused his research on stroke prevention -- research that is beginning to pay off.

In published animal studies, Rink's lab has discovered that brain damage during a stroke can be prevented by triggering the surrounding blood vessels to dilate and redirect the blood flow around a blockage.

The blood vessel "redirect" is the result of 10 weeks' worth of supplementation with a little-known type of vitamin E called tocotrienol. Tocotrienol appears to stimulate arteriogenesis -- or the remodeling of existing blood vessels that can instantaneously expand in response to a demand for oxygen-rich blood. This collateral blood supply can make a major difference in stroke outcomes.

"We know that people who have good collaterals have better recovery from strokes. We think that tocotrienol helps improve the function of collaterals, which would offer someone better protection from an initial or secondary stroke," says Rink, who is currently participating in a study of stroke survivors to see if the supplement can help prevent or reduce damage from secondary strokes -- which can often be more disabling and costly than the first stroke.

To find out exactly how tocotrienol is impacting blood vessel remodeling, Rink pioneered a technique using laser capture microdissection (LCM) to take microscopic pieces of brain tissue and blood vessels from the exact area where collaterals are called into action during a stroke.

The LCM samples also give Rink a chance to study micro-RNA activity during a stroke. Micro-RNAs are tiny snippets of non-coding DNA that turn off the production of proteins created by genes, proteins that give cells a range of different instructions. By identifying the micro-RNAs, Rink will be able to find out what's happening at a genetic level during a stroke, and how tocotrienol may be influencing those genes.

Tocotrienol, found naturally in palm oil, is a vitamin E variant and currently available in stores as an oral nutritional supplement. Because it doesn't appear to interfere with other stroke therapies like blood thinners, or have any other side effects, Rink thinks that the vitamin could someday become a common stroke prevention strategy, much like low-dose aspirin is currently recommended for cardiac patients.


Story Source:

The above story is based on materials provided by Ohio State University Center for Clinical and Translational Science. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University Center for Clinical and Translational Science. "Brain saver: Vitamin E supplement helps 'redirect' blood during stroke." ScienceDaily. ScienceDaily, 29 April 2014. <www.sciencedaily.com/releases/2014/04/140429085116.htm>.
Ohio State University Center for Clinical and Translational Science. (2014, April 29). Brain saver: Vitamin E supplement helps 'redirect' blood during stroke. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/04/140429085116.htm
Ohio State University Center for Clinical and Translational Science. "Brain saver: Vitamin E supplement helps 'redirect' blood during stroke." ScienceDaily. www.sciencedaily.com/releases/2014/04/140429085116.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins